source
- Big pharma holds $188 bn for M&A, J&J seen as most likely buyer, analysis showsThe latest Leerink Partners analysis finds that the largest pharmaceutical companies collectively have about $188 billion in cash available for mergers and acquisitions. All but one of the firms su…
- FDA issues draft guidance to streamline approval of personalized gene therapies and expands CMS access modelThe Food and Drug Administration released a draft guidance that lets a single biologics license application cover multiple variants of a gene‑therapy product. The guidance introduces an Individuali…